Scherer LJ - Search Results

1

Approaches for the sequence-specific knockdown of mRNA.

Scherer LJ, Rossi JJ. Scherer LJ, et al. Nat Biotechnol. 2003 Dec;21(12):1457-65. doi: 10.1038/nbt915. Nat Biotechnol. 2003. PMID: 14647331 Review.

2

RNAi applications in mammalian cells.

Scherer L, Rossi JJ. Scherer L, et al. Biotechniques. 2004 Apr;36(4):557-61. doi: 10.2144/04364TE01. Biotechniques. 2004. PMID: 15088371 Free article. No abstract available.

3

Recent applications of RNAi in mammalian systems.

Scherer L, Rossi JJ. Scherer L, et al. Curr Pharm Biotechnol. 2004 Aug;5(4):355-60. doi: 10.2174/1389201043376724. Curr Pharm Biotechnol. 2004. PMID: 15320766 Review.

4

Therapeutic applications of RNA interference: recent advances in siRNA design.

Scherer L, Rossi JJ. Scherer L, et al. Adv Genet. 2004;52:1-21. doi: 10.1016/S0065-2660(04)52001-1. Adv Genet. 2004. PMID: 15522731 Review. No abstract available.

5

Interplay between HIV-1 infection and host microRNAs.

Sun G, Li H, Wu X, Covarrubias M, Scherer L, Meinking K, Luk B, Chomchan P, Alluin J, Gombart AF, Rossi JJ. Sun G, et al. Nucleic Acids Res. 2012 Mar;40(5):2181-96. doi: 10.1093/nar/gkr961. Epub 2011 Nov 10. Nucleic Acids Res. 2012. PMID: 22080513 Free PMC article.

6

Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.

Pang KM, Castanotto D, Li H, Scherer L, Rossi JJ. Pang KM, et al. Nucleic Acids Res. 2018 Jan 9;46(1):e6. doi: 10.1093/nar/gkx980. Nucleic Acids Res. 2018. PMID: 29077949 Free PMC article.

7

Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers.

Han SP, Scherer L, Gethers M, Salvador AM, Salah MBH, Mancusi R, Sagar S, Hu R, DeRogatis J, Kuo YH, Marcucci G, Das S, Rossi JJ, Goddard WA 3rd. Han SP, et al. Mol Ther Nucleic Acids. 2022 Jan 3;27:797-809. doi: 10.1016/j.omtn.2021.12.039. eCollection 2022 Mar 8. Mol Ther Nucleic Acids. 2022. PMID: 35116191 Free PMC article.

8

Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.

Chang Z, Westaway S, Li S, Zaia JA, Rossi JJ, Scherer LJ. Chang Z, et al. Among authors: scherer lj. Mol Ther. 2002 Oct;6(4):481-9. doi: 10.1006/mthe.2002.0696. Mol Ther. 2002. PMID: 12377189 Free article.

9

Rapid assessment of anti-HIV siRNA efficacy using PCR-derived Pol III shRNA cassettes.

Scherer LJ, Yildiz Y, Kim J, Cagnon L, Heale B, Rossi JJ. Scherer LJ, et al. Mol Ther. 2004 Sep;10(3):597-603. doi: 10.1016/j.ymthe.2004.05.003. Mol Ther. 2004. PMID: 15336659 Free article.

10

Optimization and characterization of tRNA-shRNA expression constructs.

Scherer LJ, Frank R, Rossi JJ. Scherer LJ, et al. Nucleic Acids Res. 2007;35(8):2620-8. doi: 10.1093/nar/gkm103. Epub 2007 Apr 10. Nucleic Acids Res. 2007. PMID: 17426139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters